Skip to content

Ming Li, M.D., PH.D.

NPI 1982702056ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· San Jose, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D., PH.D.) in San Jose, California, licensed in CA, with an NPI issued in September 2006. Part D covered 27 prescriptions written in 2024, 85% of them generic. Regeneron Healthcare Solutions, Inc. was the largest of 6 companies reporting payments in 2025, $174.73 in all, mostly food and beverage.

Overview

NPI1982702056
StatusActive
Entity typeIndividual
CredentialM.D., PH.D.
Sole proprietorYes
NPI issuedSep 20, 2006
Last updated in NPPESSep 25, 2012

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)27 · 79 30-day fills
Total drug cost$202.01
Generic share85% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$174.73 · 7 payments from 6 companies
  • 2024$172.27 · 6 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$174.73 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in San Jose

All 21 endocrinologists in San Jose · All endocrinologists in California